Buruli ulcer: Differences in treatment outcome between two centres in Ghana

Acta Tropica

Volumn 88, Issue 1, 2003, Pages 51-56

  Teelken, M A ^a   Stienstra, Y ^a   Ellen, D E ^a   Quarshie, E ^b   Klutse, E ^c   Van Der Graaf, W T A ^a   Van Der Werf, Tjip S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Agogo Presbyterian Hospital   (Ghana)

^c Dunkwa Hospital   (Ghana)

Author keywords

Follow up; Ghana; Mycobacterium ulcerans; Surgery

Indexed keywords

BCG VACCINE; RIFAMPICIN;

COMPARATIVE STUDY; HEALTH CARE; PERFORMANCE ASSESSMENT;

ARTICLE; BCG VACCINATION; BURULI ULCER; CHILD; CONTROLLED STUDY; EXCISION; FOLLOW UP; GHANA; HEALTH CENTER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPOTHESIS; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIVARIATE ANALYSIS; MYCOBACTERIUM ULCERANS; PATIENT SELECTION; SKIN SURGERY; SKIN ULCER; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME; ULCER HEALING;

GHANA;

MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM ULCERANS;

EID: 0042967610     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(03)00170-0     Document Type: Article

References (13)

1. Aguiar J., Stenou C. Les ulcères de Buruli en zone rurale au Benin: prise en charge de 635 cas. Med. Trop. (Mars.). 57:1997;83-90.
2. Amofah G.K., Sagoe-Moses C., Adjei-Acquah C., Frimpong E.H. Epidemiology of Buruli ulcer in Amansie West district, Ghana. Trans. R. Soc. Trop. Med. Hyg. 87:1993;644-645.
3. Amofah G., Asamoah S., Afram-Gyening C. Effectiveness of excision of pre-ulcerative Buruli lesions in field situations in a rural district in Ghana. Trop. Doct. 28:1998;81-83.
4. Asiedu K., Scherpbier R.W., Raviglione M. Buruli ulcer-Mycobacterium ulcerans infection. 2000;WHO.
5. Dobos K.M., Quinn F.D., Ashford D.A., Horsburgh C.R., King C.H. Emergence of a unique group of necrotizing mycobacterial diseases. Emerg. Infect. Dis. 5:1999;367-378.
6. Ellen D.E., Stienstra Y., Teelken M.A., Dijkstra P.U., Van der Graaf W.T.A., Van der Werf T.S. Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli ulcer functional limitation score. Trop. Med. Int. Health. 8:2003;90-96.
7. Josse R., Guedenon A., Darie H., Anagonou S., Portaels F., Meyers W.M. Les infections cutanées a Mycobacterium ulcerans: ulcères de Buruli. Med. Trop. (Mars.). 55:1995;363-373.
8. Krieg R.E., Wolcott J.H., Meyers W.M. Mycobacterium ulcerans infection: treatment with rifampin, hyperbaric oxygenation, and heat. Aviat. Space Environ. Med. 50:1979;888-892.
9. Meyers W.M., Shelly W.M., Connor D.H., Meyers E.K. Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am. J. Trop. Med. Hyg. 23:1974;919-923.
10. Muelder K. Wounds that will not heal: the Buruli ulcer. Int. J. Dermatol. 31:1992;25-26.
11. Smith P.G., Revill W.D., Lukwago E., Rykushin Y.P. The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda. Trans. R. Soc. Trop. Med. Hyg. 70:1977;449-457.
12. van der Werf T.S., van der Graaf W.T., Groothuis D.G., Knell A.J. Mycobacterium ulcerans infection in Ashanti region, Ghana. Trans. R. Soc. Trop. Med. Hyg. 83:1989;410-413.
13. van der Werf T.S., van der Graaf W.T., Tappero J.W., Asiedu K. Mycobacterium ulcerans infection. Lancet. 354:1999;1013-1018.